ASHBURN, Va., Aug. 13, 2025 /PRNewswire/ -- Abich Financial Services ranked number 3836 on the 2025 Inc. 5000 list of the fastest-growing private companies...
Los Angeles, CA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (“BioSig” or the “Company”) which recently merged with Streamex Exchange Corporation (“Streamex”) (NASDAQ: BSGM) today announced its intention to offer shares of common stock (or pre-funded warrants in lieu thereof) through an underwritten public offering. All of the shares of common stock (or pre-funded warrants in lieu thereof) are being offered by the Company. The completion of the offering remains subject to market conditions, with no assurance regarding its timing, size, or terms. The Company intends to use the net proceeds from the offering to purchase gold bullion in accordance with its investment policy, for working capital and for general corporate purposes.
The Interim Consolidated Financial Statements of Eik fasteignafélag hf. for the period 1 January to 30 June 2025 were approved by the Company’s Board of Directors and CEO on 13 August 2025.
"With cutting-edge advances in next-generation sequencing and growing interest in personalized medicine, whole genome sequencing is set to transform disease diagnosis and treatment, driving...
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global AI in Synthetic Biology Market size & share revenue was valued at approximately USD 24.58 Billion in 2024 and is expected to reach USD 30.76 Billion in 2025 and is expected to reach around USD 192.95 Billion by 2034, at a CAGR of 28.63% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Ginkgo Bioworks, Amyris, Thermo Fisher Scientific, Illumina, GenScript, Synthetic Genomics, Novozymes, LanzaTech, Zymergen, Twist Bioscience, Codexis, Cambrian Biopharma, Moderna, Editas Medicine, Vertex Pharmaceuticals, CRISPR Therapeutics, Arbor Biotechnologies, Synthego, Evonik Industries, Cargill, Others and others.
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global AI in Synthetic Biology Market size & share revenue was valued at approximately USD 24.58 Billion in 2024 and is expected to reach USD 30.76 Billion in 2025 and is expected to reach around USD 192.95 Billion by 2034, at a CAGR of 28.63% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Ginkgo Bioworks, Amyris, Thermo Fisher Scientific, Illumina, GenScript, Synthetic Genomics, Novozymes, LanzaTech, Zymergen, Twist Bioscience, Codexis, Cambrian Biopharma, Moderna, Editas Medicine, Vertex Pharmaceuticals, CRISPR Therapeutics, Arbor Biotechnologies, Synthego, Evonik Industries, Cargill, Others and others.
BISMARCK, N.D., Aug. 13, 2025 /PRNewswire/ -- Indigenized Energy, a Native-led nonprofit dedicated to advancing tribal energy sovereignty, is proud to announce the completion of...
DELRAY BEACH, Fla., Aug. 13, 2025 /PRNewswire/ -- The report 'Doors Market by Material, Product Type, Mode of Application, Mechanism (Sliding Doors, Swinging Doors,...
DELRAY BEACH, Fla., Aug. 13, 2025 /PRNewswire/ -- The report 'Doors Market by Material, Product Type, Mode of Application, Mechanism (Sliding Doors, Swinging Doors,...
DELRAY BEACH, Fla., Aug. 13, 2025 /PRNewswire/ -- The report "Automotive Refinish Coatings Market by Layer (Clearcoat, Basecoat, Primer), Resin Type (Polyurethane, Epoxy, Acrylic, Alkyd),...
DELRAY BEACH, Fla., Aug. 13, 2025 /PRNewswire/ -- The report "Automotive Refinish Coatings Market by Layer (Clearcoat, Basecoat, Primer), Resin Type (Polyurethane, Epoxy, Acrylic, Alkyd),...